AT‐Rich–Interactive Domain–Containing Protein 5A Functions as a Negative Regulator of Retinoic Acid Receptor–Related Orphan Nuclear Receptor γt–Induced Th17 Cell Differentiation
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objective: The proinflammatory cytokines tumor necrosis factor α and interleukin‐6 (IL‐6) and the Th17 cell cytokine IL‐17A are implicated in the pathogenesis of rheumatoid arthritis (RA), and the blockade of these cytokines by biologic agents provides clinical benefits for RA patients. We undertook this study to clarify the mechanisms underlying the efficacy of IL‐6 blockade in RA and to find a novel target for treatment of RA. Methods: We examined gene expression profiles of CD4+ T cells by DNA microarray analysis before and after treatment with an anti–IL‐6 receptor antibody, tocilizumab (TCZ), in RA patients who exhibited good clinical responses to the treatment. Using murine CD4+ T cells, we then examined the roles of a newly identified molecule whose expression was significantly reduced in CD4+ T cells by TCZ therapy. We also examined the effect of the forced expression of the molecule on retinoic acid receptor–related orphan nuclear receptor γt (RORγt)–induced IL‐17A production in CD4+ T cells and on RORγt‐induced IL‐17A promoter activation. Results: We identified AT‐rich–interactive domain– containing protein 5A (ARID‐5A) as a new molecule down‐regulated by IL‐6 blockade in the form of TCZ therapy. IL‐6 induced the expression of ARID‐5A in CD4+ T cells during Th17 cell differentiation by a STAT‐3–dependent mechanism, whereas IL‐6–induced ARID‐5A expression was not affected by the absence of RORγt, a lineage‐specifying transcription factor of Th17 cells. Furthermore, ARID‐5A physically associated with RORγt through its N‐terminal region and inhibited RORγt‐induced Th17 cell differentiation. Conclusion: ARID‐5A is a lineage‐specific attenuator of Th17 cell differentiation and may be involved in the pathogenesis of RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669
Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis.
Choy, E. (2012) · Rheumatology · doi:10.1093/rheumatology/kes113 · Cited by 816
Maini, R. N., Taylor, P. C., Szechinski, J., Pavelka, K., Bröll, J., Balint, G., Emery, P., Raemen, F., Petersen, J., Smolen, J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22033 · Cited by 790
Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
Solt, L. A., Kumar, N., Nuhant, P., Wang, Y., Lauer, J. L., Liu, J., Istrate, M. A., Kamenecka, T. M., Roush, W. R., Vidović, D., et al. (2011) · Nature · doi:10.1038/nature10075 · Cited by 508
Type 17 T helper cells-origins, features and possible roles in rheumatic disease.
Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., & Romagnani, S. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.80 · Cited by 212 · cited 1×
“Over the last decade, a number of studies have revealed that not only Th1 cells, but also Th17 cells are involved in the pathogenesis of RA (6,7,35,36).”
Background
Cited by
Interleukin-6 and its receptors: a highly regulated and dynamic system
Wolf, J., Rose-John, S., & Garbers, C. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.024 · Cited by 618
Regulation of IL-6 in Immunity and Diseases
Tanaka, T., Narazaki, M., Masuda, K., & Kishimoto, T. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-024-0921-5_4 · Cited by 235
TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a
Nyati, K. K., Masuda, K., Zaman, M. M.-U., Dubey, P. K., Millrine, D., Chalise, J. P., Higa, M., Li, S., Standley, D. M., Saito, K., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx064 · Cited by 190
IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
Kishimoto, T., & Kang, S. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101220-023458 · Cited by 140
Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA
Masuda, K., Ripley, B., Nyati, K. K., Dubey, P. K., Zaman, M. M.-U., Hanieh, H., Higa, M., Yamashita, K., Standley, D. M., Mashima, T., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151289 · Cited by 88
Metadata
- Authors
- Saito, Y., Kagami, S., Sanayama, Y., Ikeda, K., Suto, A., Kashiwakuma, D., Furuta, S., Iwamoto, I., Nonaka, K., Ohara, O., & Nakajima, H.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2014-04-28
- Volume
- 66
- Issue
- 5
- Pages
- 1185-1194
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W1582114550
- Cited by
- 40
- References
- 5
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AT‐Rich–Interactive Domain–Containing Protein 5A Functions as a Negative Regulator of Retinoic Acid Receptor–Related Orphan Nuclear Receptor γt–Induced Th17 Cell Differentiation. https://app.cochat.ai/papers/10.1002/art.38324
- The paper
- Saito, Y., Kagami, S., Sanayama, Y., Ikeda, K., Suto, A., Kashiwakuma, D., Furuta, S., Iwamoto, I., Nonaka, K., Ohara, O., & Nakajima, H. (2014). AT‐Rich–Interactive Domain–Containing Protein 5A Functions as a Negative Regulator of Retinoic Acid Receptor–Related Orphan Nuclear Receptor γt–Induced Th17 Cell Differentiation. Arthritis & Rheumatology. https://doi.org/10.1002/art.38324
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.